Dissertation (Ph. D.)--University of Akron, Dept. of Polymer Engineering, 2007. / "December, 2007." Title from electronic dissertation title page (viewed 01/30/2008) Advisor, Kyonsuku Min; Committee members, Mark Soucek, Kevin A. Cavicchi, Gary R. Hamed, Michael H. Cheung; Department Chair, Sadhan C. Jana; Dean of the College, Stephen Z. D. Cheng; Dean of the Graduate School, George R. Newkome. Includes bibliographical references.

No description available.

published_or_final_version / Chemistry / Doctoral / Doctor of Philosophy

published_or_final_version / Chemistry / Doctoral / Doctor of Philosophy

Thesis--Ph. D., University of Hong Kong. / Mimeographed.

Thesis--Ph. D., University of Hong Kong. / Typewritten.

Thesis (Ph. D.)--University of Illinois. / "Biographical": 1 p. at end. "Under the title 'The ionization and hydration relations of electrolytes in aqueous solution at zero degrees: A. Cesium nitrate, potassium chloride and lithium chloride, ' this thesis was published in the J. Am. Chem. Soc., 33, 1686-1713 (1911) as the third article in a series entitled, 'The laws of "concentrated" solutions'": p. [3].

Thesis (Ph. D.)--University of Illinois. / "Biographical": 1 p. at end. "Under the title 'The ionization and hydration relations of electrolytes in aqueous solution at zero degrees: A. Cesium nitrate, potassium chloride and lithium chloride, ' this thesis was published in the J. Am. Chem. Soc., 33, 1686-1713 (1911) as the third article in a series entitled, 'The laws of "concentrated" solutions'": p. [3].

Thesis (Ph. D.)--Johns Hopkins University, 1921. / Biography.

Whole document restricted, see Access Instructions file below for details of how to access the print copy. / Huntington’s disease [HD] is a debilitating adult onset inherited neurodegenerative disorder with primary degeneration in the striatum and widespread secondary degeneration throughout the brain. There are currently no clinical treatments to prevent onset, delay progression or replace lost neurons. Striatal cell transplantation strategies under clinical evaluation appear viable and effective for the treatment of HD. However, the future of regenerative medicine lies in developing renewable, expandable multipotent neural cell sources for transplantation. This Thesis has investigated a range of novel developments for enhancing the therapeutic potential of neural progenitor cell transplantation in a quinolinic acid [QA] lesion rat model of HD using two cell sources, adult neural progenitor cells and human embryonic stem cell [hESC] derived neural progenitor cells. Chapter Three identified a novel method for in vitro lithium priming of adult neural progenitor cells which enhances their neurogenic potential at the expense of glial formation. Chapter Four demonstrated that lithium priming of adult neural progenitor cells altered their phenotypic fate in vivo after transplantation, enhancing regional specific differentiation and efferent projection formation. The therapeutic potential of this strategy was demonstrated by accelerated acquisition of motor function benefits in the QA model. Chapter Five then demonstrated the ability for post transplantation environmental enrichment to modify therapeutic functional outcomes in the QA lesion model, and through lithium priming and enrichment demonstrated that adult neural progenitors are amenable to combinatorial interventions which can alter their phenotypic fate and enhance anatomical integration. Chapter Six investigated the in vivo effects of in vitro noggin priming of hESC derived neural progenitor cells and identified enhanced safety and neuronal differentiation in the QA lesioned striatum after noggin priming. Furthermore Chapter Seven provided evidence for functional reconstruction and therapeutic functional benefits from transplantation of noggin primed hESC derived neural progenitor cells and also highlighted the need for systematic evaluations of hESC derived transplants to optimise their safety in vivo. These results are beneficial in demonstrating the realistic therapeutic potential held by these two cell sources. They demonstrate how transient interventions can enhance therapeutic outcomes of neural progenitor cell transplantation for HD and have developed the understanding of neural progenitor cell transplantation as a therapeutic tool, bringing transplantation from different cell sources closer to eventual translation for HD sufferers.